Abstract
The pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM) has been the subject of debate for many years, and it still remains poorly understood [55, 82]. Current dogma states that it is a heterogeneous disorder; indeed, several patients have now been identified with mutant insulins [63, 69] or one of a variety of syndromes characterized by abnormal insulin receptors, extreme insulin resistance, and acanthosis nigricans [16,17,29]. Also, in some series, up to 10% are islet cell antibody-positive [14]. However, these groups together represent only a small minority of those with NIDDM, and while new syndromes will probably be described in the future, it seems reasonable to assume that the bulk of patients share a common etiology.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This work has been supported by grant AM-35449 (formerly Am-29349) from the National Institutes of Health, and 185296 from the Juvenile Diabetes Foundation. Dr. Leahy is the recipient of a Research and Development Award from the American Diabetes Association.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM (1984) Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33: 634–642
Bevilacqua S, Barrett EJ, Smith D, Simonson DC, Olsson M, Bratusch-Marrain P, Ferrannini E, DeFronzo RA (1985) Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog. Metabolism 34: 817–825
Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238–1246
Bonner-Weir S, Trent DF, Honey RN, Weir GC (1981) Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 30: 64–69
Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC (1981) Limited B-cell regeneration in a B-cell deficient rat model: studies with dexamethasone. Metabolism 30: 914–918
Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71:1544–1554
Bonner-Weir S, Brockenbrough JS, Weir GC (1985) Discordance of exocrine and B cell growth following partial pancreatectomy. Diabetes 34:169 A
Bonner-Weir S, Deery D, Weir GC (1986) Growth of regenerating islet tissue is enhanced by VMH lesions. Diabetes 35: 97A
Brodsky GM, Kern HF, Logothetopoulos J (1972) Ultrastructure, mitotic activity and insulin biosynthesis of pancreatic beta cells stimulated by glucose infusions. Fed Proc 31: 250
Cantenys D, Portha B, Dutrillaux MC, Hollande E, Roze C, Picon L (1981) Histogenesis of the endocrine pancreas in newborn rats after destruction by streptozotocin: an immunocytochemical study. Virchows Arch B 35:109–122
Cerasi E, Luft R (1967) The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55: 278–304
Cole E, Logothetopoulos J (1974) Glucose oxidation (14CO2 production) and insulin secretion by pancreatic islets isolated from hyperglycemic and normoglycemic rats. Diabetes 23: 469–473
Deckert T, Lauritsen UB, Madsen SN, Morgensen P (1972) Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus. Dan Med Bull 19: 222–226
DiMario U, Irvine WJ, Borsey DQ, Kyner JL, Weston J, Galfo C (1983) Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 25: 392–395
Dutrillaux MC, Portha B, Roze C, Hollande E (1982) Ultrastructural study of pancreatic B-cell regeneration in newborn rats after desctruction by streptozotocin. Virchows Arch B 39: 173–185
Flier JS, Young JB, Landberg L (1980) Familial insulin resistance with acanthosis nigricans, acral hypertrophy and muscle cramps. N Engl J Med 303: 970–973
Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW (1985) Acanthosis nigricans in obese women with hyperandrogenism: characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes 34:101–107
Foglia VG (1944) Caracteristicas de la diabetes en la rata. Rev Soc Argent Biol 20: 21–37
Frohman LA, Bernardis LL, Schnatz JD, Burek L (1969) Plasma insulin and triglyceride levels after hypothalamic lesions in weanling rats. Am J Physiol 216:1496–1501
Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS (1984) Differential sensitivity to beta cell secretagogues in “early” type I diabetes mellitus. Diabetes 33:516–521
Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34: 222–234
Gepts W (1957) Contribution à l’étude morphologique des ilôts de Langerhans au cours du diabète. Ann Soc R Sci Med Natur Brüx 10: 5–108
Gepts W, LeCompte PM (1981) The pancreatic islets in diabetes. Am J Med 70:105–115
Giroix MH, Portha B, Kergoat M, Balbe D, Picon L (1983) Glucose insensitivity and amino acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes: a study with the perfused pancreas. Diabetes 32: 445–451
Grill V, Rundfeldt M (1986) Abnormalities of insulin response after ambient and previous exposure to glucose in streptozotocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands. Diabetes 35: 44–51
Hales CN, Kennedy GC (1964) Plasma glucose, non-esterified fatty acid and insulin concentrations in hypothalamic-hyperphagic rats. Biochem J 90: 620–624
Halter JB, Graf RJ, Porte D Jr (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946–954
Hidaka H, Nagulesparan M, Klimes I, Clark R, Sasaki H, Aronoff SL, Vasquez B, Rubenstein AH, Unger RH (1982) Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetes. J Clin Endocrinol Metab 54: 217–222.
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J (1976) The syndrome of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N Engl J Med 294: 739–745
Kergoat M, Portha B (1985) In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozotocin. Assessment with the insulin-glucose clamp technique. Diabetes 34:1120–1126
Kingston ME, Skoog WC (1986) Maintenance of basal insulin secretion in severe non-insulin-dependent diabetes. Diabetes Care 9: 232–235
Kosaka K, Kuzuya T, Akanuma Y, Hagura R (1980) Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 18: 23–28
Kosuga M, Akanuma Y, Iwamoto Y, Kosaka K (1978) Insulin binding and glucose metabolism in adipocytes of streptozotocin-diabetic rats. Am J Physiol 235: E175–E182
Lang DA, Matthews DR, Peto J, Turner RC (1979) Cyclic oscillations of basal plasma glucose and insulin concentration in human beings. N Engl J Med 301:1023–1027
Leahy JL, Weir GC (1985) Unresponsiveness to glucose in a streptozotocin model of diabetes: inappropriate insulin and glucagon responses to a reduction of glucose concentration. Diabetes 34: 653–659
Leahy JL, Bonner-Weir S, Weir GC (1984) Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33: 667–673
Leahy JL, Bonner-Weir S, Weir GC (1985) Abnormal insulin secretion in a streptozotocin model of diabetes: effects of insulin treatment. Diabetes 34: 660–666
Leahy JL, Cooper HE, Deal DA, Weir GC (1986) Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77: 908–915
Leahy JL, Cooper HE, Weir GC (1987) Impaired insulin secretion associated with near-nor-moglycemia. A study in normal rats using 96 hour in vivo glucose infusions. Diabetes 36: 459–464
Levy J, Gavin JR, Fausto A, Gingerich RL, Avioli LV (1984) Impaired insulin-action in rats with non-insulin-dependent diabetes. Diabetes 33: 901–906
Logothetopoulos J, Kaneko M, Wrenshall GA, Best CH (1964) Zinc, granulation and extractable insulin of islet cells following hyperglycemia or prolonged treatment with insulin. In: Brolin SE, Kellman B, Knutson K (eds) The structure and metabolism of the pancreatic islets. Pergamon, Oxford
Lukens FDW, Dohan FC (1942) Pituitary-diabetes in the cat: recovery following insulin or dietary treatment. Endocrinology 30:175–202
Maclean N, Ogilvie RF (1955) Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4: 367–376
Mako ME, Starr JI, Rubenstein AH (1977) Circulating proinsulin in patients with maturity onset diabetes. Am J Med 63: 865–869
Matthaei S, Horuk R, Olefsky JM (1986) Blood-brain glucose transfer in diabetes mellitus: decreased number of glucose transporters at blood-brain barrier. Diabetes 35:1181–1184
McCulloch DK, Raghu PK, Klaff LJ, Koerker DJ, Palmer PJ (1985) Impaired glucose potentiation of arginine-stimulated insulin release is a sensitive and reliable marker of B-cell damage. Diabetes 34: 85 A
Olefsky JM, Kolterman OG (1981) Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med 70:151–168
Palmer JP, Benson JW, Walter RM, Ensinck JW (1976) Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest 58: 565–570
Penhos JC, Wu CH, Basabe JC, Lopez N, Wolff FW (1969) A rat pancreas-small gut preparation for the study of intestinal factor(s) and insulin release. Diabetes 18: 733–738
Portha B, Kergoat M (1985) Dynamics of glucose-induced insulin release during the spontaneous remission of streptozotocin diabetes induced in the newborn rat. Diabetes 34: 574–579
Portha B, Levacher C, Picon L, Rosselin G (1974) Diabetogenic effect of streptozotocin in the rat during perinatal period. Diabetes 23: 889–895
Portha B, Levacher C, Picon L, Rosselin G (1974) Diabetogenic effect of streptozotocin in the rat during perinatal period. Diabetes 23: 889–895
Portha B, Picon L, Rosselin G (1979) Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17: 371–377
Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of human diabetic pancreas. Diabetologia 24: 366–371
Randle PJ, Garland PB, Hales CN, Newholne EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785–789
Reaven GM (1984) Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary? Diabetes Care 7 [Suppl 1]: 17–24
Reaven G, Miller R (1968) Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17: 560–569
Reaven GM, Sageman WS, Swenson RS (1977) Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency. Diabetologia 13: 459–462
Revers RR, Fink R, Griffin J, Olefsky JM, Kolterman OG (1984) Influence of hyperglycemia on insulin’s in vivo effects in type II diabetes. J Clin Invest 73: 664–672
Rossetti L, Papachristou D, Shulman G, Smith D, DeFronzo R (1986) Insulin resistance in partially pancreatectomized rats: reversal with phloridzin therapy. Diabetes 35: 38 A
Saito K, Yaginuma N, Takahashi T (1979) Differential volumetry of A, B, and D Cells in the pancreatic islets of diabetic and non-diabetic subjects. Tohoku J Exp Med 129: 273–283
Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG (1982) Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5: 353–363
Seltzer HS, Allen EW, Herron AL, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46: 323–335
Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A,Tager H (1983) Three mutant insulin in man. Nature 302: 540–543
Simonson D, Ferrannini E, Bevilacqua S, Smith D, Barrett E, Carlson R, DeFronzo RA (1984) Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 33:838–845
Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS (1984) Pretype I diabetes: linear loss of beta cell response to intravenous glucose. Diabetes 33:717–720
Starke A, Grundy S, McGarry JD, Unger RH (1985) Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-dependent dogs: implications for human diabetes. Proc Natl Acad Sci USA 82:1544–1546
Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH (1982) Quantitation of endocrine cell content in the pancreas of non-diabetic and diabetic humans. Diabetes 31: 694–700
Swenne I (1982) The role of glucose in the in vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic B-cells. Diabetes 31: 754–760
Tager HS (1984) Abnormal products of the human insulin gene. Diabetes 33: 693–699
Tomita T, Lacy PE, Matschinsky FM, McDaniel ML (1974) Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro. Diabetes 23: 517–524
Toreson WE (1951) Glycogen infiltration (so-called hydropic degeneration) in the pancreas of human and experimental diabetes mellitus. Am J Pathol 27: 327–347
Trent DF, Fletcher DJ, May JM, Bonner-Weir S, Weir GC (1984) Abnormal islet and adipocyte function in young B-cell-deficient rats with nearnormoglycemia. Diabetes 33:170–175
Truglia JA, Livingston JN, Lockwood DH (1985) Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus. Am J Med 79 B): 13–22
Turner RC, McCarthy ST, Holman RR, Harris E (1976) Beta-cell function improved by supplementary basal insulin secretion in mild diabetes. Br Med J 1:1252–1254
Unger RH, Grundy S (1985) Hyperglycemia as an inducer as well as a consequence of impaired islet function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119–121
Vague P, Moulin JP (1982) The defective glucose sensitivity of the B-cell in non-insulin-dependent diabetes: improvement after 24 hours of normoglycemia. Metabolism 31:139–142
Volk BW, Wellman KF (1977) Hormonal diabetes. In: Volk BW, Wellman KF (eds) The diabetic pancreas. Plenum, New York, pp 271–290
Ward WK, Beard JC, Halter JB, Pfeiffer MA, Porte Jr (1984) Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 7: 491–502
Ward WK, Taborsky GJ, Beard JC (1986) Reduced maximal potentiation of the insulin response to arginine: a sensitive indicator of B-cell damage. Diabetes 35: 98 A
Weibel ER (1963) Principles and methods for the morphometric studies of the lung and other organs. Lab Invest 12:131–155
Weir GC, Clore ET, Zmachinski CJ, Bonner-Weir S (1981) Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 30: 590–595
Weir GC (1982) Non-insulin-dependent diabetes mellitus: interplay between B-cell inadequacy and insulin resistance. Am J Med 13: 461–464
Weir GC, Leahy JL, Bonner-Weir S (1986) Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab Rev 2:125–161
Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15: 417–421
Yamamoto H, Uchigata Y, Okamoto A (1981) Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets. Nature 294: 284–286
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leahy, J.L., Bonner-Weir, S., Weir, G.C. (1988). Rat Models of Non-Insulin-Dependent Diabetes Mellitus: Evidence that Mild Increases in Plasma Glucose Play an Important Role in Pathogenesis. In: Lefèbvre, P.J., Pipeleers, D.G. (eds) The Pathology of the Endocrine Pancreas in Diabetes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72691-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-72691-0_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72693-4
Online ISBN: 978-3-642-72691-0
eBook Packages: Springer Book Archive